Huating Chen1,2†Gongchi Li5†Yiqiong Liu2
Shuaifei Ji2Yan Li2,3Jiangbing Xiang2,4Laixian Zhou2Huanhuan Gao2Wenwen Zhang1
Xiaoyan Sun2*Xiaobing Fu2*Binghui Li1*- 1Department of Wound Repair Surgery, Institute of Geriatric Medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2Research Center for Tissue Repair and Regeneration Affiliated to the Medical Innovation Research Department and 4th Medical Center, PLA General Hospital and PLA Medical College; PLA Key Laboratory of Tissue Repair and Regenerative Medicine and Beijing Key Research Laboratory of Skin Injury, Repair and Regeneration; Research Unit of Trauma Care, Tissue Repair and Regeneration, Chinese Academy of Medical Sciences, Beijing, China
- 3Department of Southern Hospital of Southern Medical University, Southern Medical University, Guangzhou, China
- 4Department of School of Biological Engineering, Chongqing University, Chongqing, China
- 5Chongqing University, Chongqing, China
Wound healing is a multi-step process that includes multiple cellular events such as cell proliferation, cell adhesion, and chemotactic response as well as cell apoptosis. Accumulating studies have documented the significance of stromal cell-derived factor-1 (SDF-1)/C-X-C chemokine receptor 4 (CXCR4) signaling in wound repair and regeneration. However, the molecular mechanism of regeneration is not clear. This review describes various types of tissue regeneration that CXCR4 participates in and how the efficiency of regeneration is increased by CXCR4 overexpression. It emphasizes the pleiotropic effects of CXCR4 in regeneration. By delving into the specific molecular mechanisms of CXCR4, we hope to provide a theoretical basis for tissue engineering and future regenerative medicine.
Introduction
The skin wound-healing process is complex and dynamic but highly carefully arranged, with intersecting sequence events between phases. It involves many kinds of cells and factors. C-X-C chemokine receptor 4 (CXCR4) is one of the most important. CXCR4 can be bound by stromal cell-derived factor-1(SDF-1), CD4 and CD74, and SDF-1 may be the only endogenous ligand of CXCR4 (1). CXCR4 plays a pivotal role in both physiological processes such as germ cell development (2), neurogenesis (3), vascular formation (4) and cardiogenesis (5) and pathological processes such as muscle regeneration (6, 7) and vascular formation (8). CXCR4 can be upregulated during injury, hypoxia, stress and vascular tissue damage (9). When tissues such as the brain (10), heart (11), kidney (12), and liver (13) are damaged, the secretion of SDF-1 can significantly increase. With wounding, CXCR4-positive stem cell/precursor cells are induced to express early tissue markers in bone marrow and participate in wound repair and regeneration. The SDF-1/CXCR4 axis can activate the major physiological processes associated with wound healing such as chemotaxis of inflammatory cells to damaged tissues (14–18), cell proliferation for wounds repair (19–23), and collagen deposition for tissue remodelling (24). The activated SDF-1/CXCR4 signaling pathway in turn activates several signaling pathways, including phosphoinositide 3 kinase (PI3K)/protein kinase B (PKB) (also known as AKT, PI3K/AKT), mammalian target of rapamycin (mTOR), and Janus kinase/signal transduction and transcription activator pathways as well as nuclear factor-activated light chain enhancer B cells (NF-κB) involved in regulating intracellular transcription, Ca2+ efflux, and cell survival (25) (Figure 1). Thus, the SDF-1/CXCR4 signal axis can transduce multiple signals to control the biological functions of cell survival, proliferation, chemotaxis, apoptosis and differentiation (26), and enhance angiogenesis in targeted diseases (8, 27, 28). So, it plays an important role in wound healing.
Figure 1 Schematic diagram of intracellular signal transduction pathways related to wound healing involving SDF-1/CXCR4. Various stimuli in vivo and in vitro will affect the expression of CXCR4 on the cell membrane, regulate the CXCR4 signaling pathway and participate in various processes of wound repair including proliferation, differentiation, and migration etc. BL-8040: antagonist of CXCR4; FIR, Far-infrared radiation; VEGF, vascular growth factor; EGF, epidermal growth factor.
A previous quantitative trait loci mapping study (29) linked SDF-1 to regenerative capacity (14). Overexpression of CXCR4 improves cell engraftment and survival as well as limb salvage and tissue regeneration after injury (30). In addition, the SDF-1/CXCR4 axis can enhance the activation of endogenous tissue repair pathways (29). Different strategies have been tried to promote tissue repair by increasing SDF-1 availability to improve the regeneration of intervertebral discs(IVD) (24), muscles (7), and liver (31) (Figure 3). Several regeneration experiments that rely on overexpressing CXCR4 tissue have achieved great success in mice and humans (6, 8, 24, 32–34). Guo et al. (32) found that the level of SDF-1 around the wound edge increased significantly after injury, and blocking this signal axis in vivo delayed wound healing. Another team (33) found that the reduced form of high mobility group box 1 can orchestrate tissue regeneration in liver and muscle. Kim et al. (6). showed that CXCR4-overexpressing adipose tissue-derived stem cells (ADSCs) more efficiently contributed to muscle tissue regeneration than normal ADSCs in a diabetic mouse model. Wei et al. (24) showed that mesenchymal stem cells (MSCs) could overexpress CXCR4 (CXCR4-MSC), which enhanced their migration and improved the speed of IVD regeneration. Activated tissue-resident MSCs can also regulate the expression of CXCR4 on natural killer cells to promote the regeneration of vasculature (8). A study of traumatic brain injury reported that the transplantation system of human umbilical-cord MSCs and activated astrocytes could be used to repair moderate-sized lesions by activating CXCR4 (34). These observations suggest that the exploration of CXCR4 and its functions have brought insights into tissue regeneration engineering and that using appropriate methods to enhance CXCR4 signaling can improve tissue regeneration. However, the specific molecular mechanism is not yet fully understood, so further experimental exploration is needed.
CXCR4 Contributes to Cutaneous Wound Healing
SDF-1/CXCR4 Signaling Induces the Inflammatory Response During Wound Healing
Because tissue damage is often accompanied by acute inflammation and tissue regeneration and the three are inevitably entangled, some experts suggest that regeneration cannot be achieved without inflammation (35). The primary function of inflammation is to eliminate the invasion of pathogens and to remove tissue necrosis, to maintain the homeostasis of tissue. Many studies have shown that CXCR4 is expressed on inflammatory cells and prime their migration ability to ischemic tissues, thereby participating in revascularization and tissue repair (14–18). In parallel, SDF-1, the ligand of CXCR4, is constitutively expressed in specific lymphoid or nonlymphoid tissues (16) and thus participates in inflammation. It seems that neutrophils majorly contribute the CXCR4/SDF-1 necessary for wound healing. Neutrophils can be first recruited early during the inflammatory response (36). Some have suggested that during the acute inflammatory reaction, the first line of defense against invading pathogens is the CXCR4hi neutrophil subsets, which rapidly migrate to the site of inflammation (17, 18, 37–39), followed by monocytes to reinforce the inflammatory reaction (37–39). Ageing neutrophils can upregulate the expression of CXCR4 on their surface, which allows them to return to the bone marrow, where they are eventually swallowed and eliminated by the resident macrophages (40), thus contributed to resolve wound inflammation. Another study found that in wild-type mouse models after tissue injury, SDF-1 is upregulated in the wound epidermis and recruits CXCR4-expressing leukocytes to the injury site (14). Then, leukocytes migrate into lesions to destroy invading microorganisms and clear debris (41)(Figure 2).
Figure 2 Roles of SDF/CXCR4 axis in regulating inflammation during wound repair. Inflammation is one of the major molecular and cellular events at the early stage of wound healing. CXCR4-expressing neutrophils can be first recruited in response to injury signals to the wound bed, followed by monocytes and Leukocytes to reinforce the inflammatory reaction. During inflammation, immune cells aggregated at the wound site, which can not only fight against invading microorganisms, but also produce various growth factors, such as FGF to direct re-epithelialization, fibroblast reconstruction and ECM remodeling. In the middle proliferative phase of wound healing, autologous or allogeneic stem cells are mobilized and migrate into the wound site, where they proliferate, secret cytokines, and participate in various cellular events in response to activation of SDF/CXCR4 signaling, including angiogenesis, muscle regeneration, and collagen synthesis. At the final stage of wound healing, immune cells progressively disappear. The fibroblasts deposit new extracellular matrix, which is gradually remodeled to form scar tissues. Blocking SDF/CXCR4 axis may result in a reduction in collagen production, thereby alleviating tissue fibrosis at the wound site. ADSCs, adipose tissue-derived stem cells; MSCs, mesenchymal stem cells. NK Cells; Natural Killer Cells. Blue arrows showing the migration/homing of cells induced by the SDF-1/CXCR4 axis.
Essentially, wound treatment represents the regeneration of the epidermis and dermis but also the restoration of skin function (42). Typically, wound healing in adult mammals, especially humans, results in scar tissue without regeneration of skin appendages. A large area of skin scars will affect the appearance of the patient and can lead to functional dysfunction such as inability to sweat and dissipate heat, thereby affecting quality of life. We are aware, however, that inflammatory responses can be both protective and deleterious in wound healing. The initiation of the early wound healing response requires the recruitment of immune cells, but the suppression of some forms of immunity can accelerate the subsequent regeneration (43). In the process of inflammation, immune cells gather at the wound site, which can not only fight against invading microorganisms, but also produce various growth factors, such as FGF to guide re-epithelialization, fibroblast reconstruction and ECM remodeling (44) (Figure 2). At the same time, inflammation can limit regeneration by promoting fibrosis and scar formation, leading to related dysfunction. The SDF-1/CXCR4 axis can promote inflammation to cause fibrosis and scar formation (14, 45). The use of the CXCR4 inhibitor AMD3100 can significantly reduce the subsequent recruitment of CXCR4-expressing leukocytes and achieve scarless repair of skin wounds and appendages regeneration in mice (14). There are also reports that AMD3100 improved wound healing and scar formation in diabetic mice (46). Thus, regulating the expression of CXCR4 temporally and spatially can provide a new and feasible way for complete scarless healing in mammals and even humans during wound healing.
CXCR4 Promotes Proliferation During Wound Healing
CXCR4 is involved in cell proliferation, which is the basis of tissue regeneration. After acute liver injury, SDF-1 and CXCR7 seem to play a major role in liver regeneration by promoting hepatocyte proliferation (19). A recent study in vitro showed that SDF-1 can improve the effect of cytokines on the clonal growth of normal myeloid progenitors (47). Also, SDF-1 may play a key role in epithelialization by promoting epidermal stem cell migration and proliferation (32). Pasha and others (48) proposed that the advancement of SDF-1a can enhance the survival, engraftment and proliferation of MSCs treated with SDF-1a/CXCR4 signaling in infarcted myocardium. Cell proliferation involves many signal axis pathways; among the numerous signal traffic networks, CXCR4 seems to play an important role. Many studies have shown that the CXCR4 signaling pathway is involved in cell proliferation (20–23). The mitogen-activated protein kinase (MAPK) pathway has also been implicated in mitogen-stimulated proliferation (20). CXCR4 binding to its ligand may lead to receptor internalization and MAPK activation to enhance cell proliferation (21). Another study suggested that SDF-1–induced cell proliferation works by activating extracellular signal-regulated kinase (ERK) (22). Moreover, SDF-1–induced ERK1/2 activation can be directly mediated by MAPK kinase 1/2 signaling with no need for synthesis of new proteins or Gαi participation (49). After acute liver injury, SDF-1 and CXCR7 seem to play a major role in liver regeneration by promoting hepatocyte proliferation (19). Far-infrared radiation can upregulate CXCR4, Nanog, Sox2, c-Kit, Nkx2.5, etc. at the mRNA and protein levels to promote cell proliferation and migration; blocking CXCR4/ERK activation can prevent far-infrared radiation-induced cell proliferation and migration (23).
CXCR4-Directed Cell Adhesion During Tissue Regeneration
Effective directional migration cannot work without adhesion (41), and it plays an important role in wound repair. Adhesion plays a role in cell survival, cell migration, inflammation, and angiogenesis, and apoptosis. These processes are essential for wound repair. The CXCR4 signal axis can affect cell adhesion by regulating the expression of adhesion molecules (50–58). SDF-1 can upregulate the expression of adhesion molecules such as very late activation antigen 4 (VLA-4[α4β1]), VLA-5, and lymphocyte function-associated antigen 1 (50–52), thereby increasing cell adhesion. Adhesion molecules have multiple ways of regulating wound healing. For example, adhesion molecule–ligand interactions are the initial process during the proper homing of hematopoietic stem cells to the bone marrow (52, 59). Cells can use β-integrins, VLA-4 and VLA-5 to bind to stromal layers, which is important for bone-marrow engraftment (55). Also, integrins such as VLA-4 can cooperate with chemokine receptors such as CXCR4 to promote the adhesion to MSCs (60). Adhesion of MSCs in turn favors cell survival and growth, proliferation, and tissue retention (60, 61). Alternatively, integrin–growth factor pairs contribute to angiogenesis via various signaling pathways, and integrins can be involved in cell survival or prime the process of apoptosis (62).
Adhesion molecules are closely related to cell migration. Cells polarize firstly before migrating. Extracellular matrix can connect to the intracellular cytoskeleton and alter cytoskeletal dynamics, with the help of integrins (63–65), thus playing a role in changing their cellular localization during cell polarization. In migrating cells, a number of adhesion molecules are concentrated in the uropod to promote the binding of other cells, thus enhancing the recruitment of leukocyte and migration of transendothelial (66). Adhesion molecule VLA-4 can be expressed on monocytes, lymphocytes and most other hematopoietic cells and plays an important role in lymphocyte trafficking and homing (67), which control matters for early stages of tissue repair. In addition, integrins are the main family of migration-promoting receptors that can significantly promote cell migration (41).
Meanwhile, with stimulation of SDF-1, VLA-4–mediated adhesion to fibronectin is increased and results in an increased overall adhesion (55). SDF-1 can not only increase integrin surface expression but also control adhesion molecules by enhancing integrin activation (52, 56). The cell adhesion effect regulated by SDF-1/CXCR4 signaling is mainly regulated by PI3K, MAPK and ERK signaling pathways, with PI3K playing a critical role. PI3K appears to be required for SDF-1α–mediated phosphorylation of focal adhesion proteins, whereas MAPK ERK1/2 is not (68). The activation of PI3K can lead to the phosphorylation of several focal adhesion components such as Crk-associated substrate, proline-rich kinase-2, focal adhesion kinase, paxillin, Crk-L, Crk, and Nck (69). PI3Ks can also regulate cell adhesion by phosphorylation of AKT (21). Other signaling pathways such as MAPK have also been reported. This adhesive interaction between cells and extracellular matrix of stromal cells increases the expression of β1, α3, α6, and αv integrins and increases tyrosine kinase activity, which in turn prevents caspase activation, thus resulting in decreased chemotherapy-induced cell death (70).
CXCR4-Mediated Chemotaxis Is Critical to Migration
Chemotaxis is a response produced by organisms to chemical substances in the external environment. Cell chemotaxis allows cells to migrate to where the relevant chemicals are located and generally perform the corresponding biological function. Cell chemotaxis provides a basis for cell migration, which is also a prominent component of tissue repair. Chemokines and chemokine receptors provide directional cues for cell migration. The hallmarks of ligand-stimulated chemotaxis are rearrangement of the cytoskeleton, polymerization and polarization of actin formation, and adhesion of pseudopods (71), to promote the migration of cells. During wound repair, cell migration mainly occurs in immune response cells like lymphocytes and stem cells, such as MSC cells, which implicated in injury repair.
Migration is a prominent component of chemotaxis. The main role of chemokines is lymphocyte trafficking (Figure 2). Cell migration is a highly ordered customized multi-step process that is also a prominent component of various tissue repair and regeneration (41). The healing of chronic wounds requires the migration of stem cells to the diseased area to replace damaged or lost cells. Effectively inducing their migration to the lesion area is a problem that requires more investigation. The function of CXCR4 offers a potential research direction to solve this problem. SDF-1 at low levels is a chemoattractant for lymphocytes but at high levels becomes a chemical repellent (72). In T lymphocytes, SDF-1 appears to depend on PI3-kinases and Src tyrosine kinases to stimulate the activation or phosphorylation of Tec kinases Itk and Rlk (73, 74). A loss-of-function Itk mutant showed impaired induced migration to SDF-1 (73). Tyrosine kinase ZAP-70 may work to enhance the migration of SDF-1; when not present in cells, the migration to SDF-1 is reduced (75). CXCR4 receptor was detected and expressed on progenitor cells and inflammatory cells, which can promote their migration to ischemic tissues, thereby participating in blood remodeling and tissue repair (15).
Stem cell-directed migration to targeted tissues is called homing. CXCR4 and its ligand SDF-1 are among the most important chemokines of stem cells (76). The activation of SDF-1/CXCR4 can induce the migration of stem cells to repair damaged tissue (77–79) and promote wound healing. CXCR4 and its ligand SDF-1 constitute the most studied chemokine–chemokine receptor axis in MSC homing (80). CXCR4 can play an important role in the migration of pre-existing or externally transplanted stem cells to the damaged site (81, 82). In addition, MSCs overexpressing CXCR4 can enhance migration to SDF-1, shown through chemotaxis experiments in vitro (24). The interaction between transplanted hematopoietic stem cells and bone-marrow endothelial cells and migration through the endothelium is the first step for hematopoietic stem cells to home properly to the bone marrow (52, 59). Kim et al. (6) considered that the homing and engraftment of ADSCs is related to the transfection efficiency of CXCR4 because transplantation of ADSCs overexpressing CXCR4 into the ischemic area of rats significantly increased ADSCsCXCR4+ homing and engraftment (Figure 2).
CXCR4-induced migration is regulated by multiple signaling pathways. Many studies have reported that the MAPK and PI3K/Akt pathways are involved in cytokine- or chemokine-induced migration of various cell types (21, 26, 83, 84), PI3K may have the more important role in cytokine- or chemokine-induced migration (68). In some cell systems, PI3-kinase–dependent signaling contributes to several aspects of the migratory machinery, including signal amplification, gradient sensing, actin reorganization and thus, cell motility (41, 85). The activation of phospholipase C (PLC), diacylglycerol-dependent protein kinase C (PKC) and calcium mobilization by chemokines have also been proposed to regulate cell adhesion and migration (86, 87). Also, CXCR4-mediated migration can be enhanced by inducing PLC/PKC-Ca2+ signalling (88). Preclinical data show that bone-marrow MSCs can promote osteosarcoma growth via PI3K/Akt and Ras/Erk intracellular cascades and may enhance metastasis via CXCR4 signaling (89) (Figure 3).
Figure 3 The various of wound healing via CXCR4 signaling pathway. Various cells expressing CXCR4 activate and participate in a series of signal networks to promote wound repair and regeneration. Recently, regeneration experiments based on the CXCR4 signaling pathway have used various stem cells as intermediate carriers. Transplanting stem cells that overexpress CXCR4, can promote repair and regeneration better through a directly or coordinate pattern. SDF-1, stromal cell derived factor-1; ADSCs, adipose tissue-derived stem cells; MSCs, mesenchymal stem cells; NK Cells, Natural Killer Cells; IVD, intervertebral disc.
CXCR4 Regulates Cellular Apoptosis During Tissue Regeneration
Apoptosis regulated by CXCR4 plays a major biological modification role in tissue regeneration. The process of tissue regeneration includes physiological processes such as cell proliferation and chemotaxis, and of course, cell apoptosis. Like cell growth, development, and proliferation, apoptosis plays an important role in the life cycle of cells. The elimination of apoptotic cells caused by the inflammatory environment is a key step in wound healing (90, 91). CXCR4 is related to cell apoptosis. Downregulated CXCR4 can induce cell apoptosis by inhibiting the PI3K/Akt/NF-κβ signaling (92). Also, the activation of Akt can modulate proapoptotic or antiapoptotic proteins via transcriptional or posttranscriptional modes (93) (Figure 1). Binding of SDF-1 to CXCR4 and CXCR7 leads to anti-apoptotic signaling via Bcl-2 as well as promotion of the epithelial to interstitial transition through the Rho-ROCK pathway and alterations in cell adhesion molecules (72). Overexpression of miR-9-5p inhibited MAPK/ERK and PI3K/AKT/mTOR pathways by inhibiting CXCR4, thereby reducing high sugar induced human umbilical cord endothelial cell conversion (94). In both in vitro and in vivo experiments, Abraham et al. (95) showed that the CXCR4 antagonist BL-8040 could induce cells apoptosis. This apoptosis was mediated by upregulation of miR-15a/miR-16-1, thus resulting in downregulation of the target genes B-cell lymphoma 2, myeloid cell leukemia 1 and cyclin-D1. The authors showed that BL-8040 can induce apoptosis by inhibiting survival signals through the AKT/ERK pathway. Moreover, miR-146a can downregulate CXCR4 expression dose- and time-dependently. Phenotype experiments revealed that miR-146a mimics can inhibit cell proliferation and cell migration and promote apoptosis by targeting CXCR4 (96). Petri’s experiment found that the ratio of transforming growth factor beta/interleukin 6 (TGF-β/IL-6) ratio is related to the expression of CXCR4 (8). In addition, Arck and Hecher et al. (97) showed that the two cytokines TGF-β and IL-6 are involved in inducing CXCR4 as well as differentiating lymphocytes while driving senescence.
Conclusion and Future Perspectives
Tissue regeneration and its application in regenerative medicine have always been urgently needed, and much energy and time have been invested in those topics. However, the form and function of tissue regeneration achieved is incomplete. CXCR4 clearly plays a pivotal role in tissue regeneration, and overexpression of CXCR4 in various stem cells can improve the survival of stem cell transplantation and induce various wound regeneration processes. At the same time, the activation of the CXCR4 signaling pathway can induce corresponding changes in multiple signaling pathways, then participate in the entire process of wound healing. This is the basis of the pleiotropic effects of CXCR4. Inhibiting the expression of CXCR4 can promote wound healing in a scarless manner during later phases of inflammation. To date, although a large body of studies deals with promoting wound healing through SDF-1/CXCR4 signaling pathway in small animals such as rats, limited progress has been made in neither large animals nor humans. Given that CXCR4 plays different roles during different periods of wound healing and regeneration, future therapies promise to achieve scarless wound healing by transplanting CXCR4 over-expressing stem cells into the wound post-injury and administrating CXCR4 inhibitors such as AMD3100 during the later phase of the wound healing. And, transition of research subjects from small animals to humans is expected to achieve the goal of perfect wound repair in the future. And, Research into wound healing may well focus on how to promote or inhibit CXCR4 signaling to differentiate stem cells into different tissues and how to provide better function in new tissue. Therefore, further study of CXCR4 may be an important way to more readily achieve tissue regeneration. Regulating the SDF-1/CXCR4 signal axis may provide a feasible method for realizing optimal wound repair and tissue regeneration.
Author Contributions
HC and GL conceived and drafted the manuscript. YLiu, SJ, YLi, JX, XS, XF, and BL discussed the concepts of the manuscript. HC, YLiu, and SJ drew the figures. LZ and HG participated in the revision of the article. WZ drew the second picture and participated in the revision of the article. All authors contributed to the article and approved the submitted version.
Funding
This work was supported in part by National Key Research and Development Plan (2018YFC1105704, 2017YFC1103304, 2016YFA0101000, 2016YFA0101002), the National Nature Science Foundation of China (81871569, 81830064, 81721092), the CAMS Innovation Fund for Medical Sciences (CIFMS, 2019-I2M-5-059) and the Military Medical Research and Development Projects (AWS17J005, 2019-126).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Ullah TR. The Role of CXCR4 in Multiple Myeloma: Cells’ Journey From Bone Marrow to Beyond. J Bone Oncol (2019) 17:100253. doi: 10.1016/j.jbo.2019.100253
2. Richardson BE, Lehmann R. Mechanisms Guiding Primordial Germ Cell Migration: Strategies From Different Organisms. Nat Rev Mol Cell Biol (2010) 11:37–49. doi: 10.1038/nrm2815
3. Cui L, Qu H, Xiao T, Zhao M, Jolkkonen J, Zhao C. Stromal Cell-Derived Factor-1 and its Receptor CXCR4 in Adult Neurogenesis After Cerebral Ischemia. Restorative Neurol Neurosci (2013) 31:239–51. doi: 10.3233/rnn-120271
4. Sainz J, Sata M. CXCR4, a Key Modulator of Vascular Progenitor Cells. Arterioscler Thromb Vasc Biol (2007) 27:263–5. doi: 10.1161/01.ATV.0000256727.34148.e2
5. Agarwal U, Ghalayini W, Dong F, Weber K, Zou YR, Rabbany SY, et al. Role of Cardiac Myocyte Cxcr4 Expression in Development and Left Ventricular Remodeling After Acute Myocardial Infarction. Circ Res (2010) 107:667–76. doi: 10.1161/circresaha.110.223289
6. Kim M, Kim DI, Kim EK, Kim CW. CXCR4 Overexpression in Human Adipose Tissue-Derived Stem Cells Improves Homing and Engraftment in an Animal Limb Ischemia Model. Cell Transplant (2017) 26:191–204. doi: 10.3727/096368916x692708
7. Gros J, Manceau M, Thome V, Marcelle C. A Common Somitic Origin for Embryonic Muscle Progenitors and Satellite Cells. Nature (2005) 435:954–8. doi: 10.1038/nature03572
8. Petri RM, Hackel A, Hahnel K, Dumitru CA, Bruderek K, Flohe SB, et al. Activated Tissue-Resident Mesenchymal Stromal Cells Regulate Natural Killer Cell Immune and Tissue-Regenerative Function. Stem Cell Rep (2017) 9:985–98. doi: 10.1016/j.stemcr.2017.06.020
9. Mousavi A. CXCL12/CXCR4 Signal Transduction in Diseases and its Molecular Approaches in Targeted-Therapy. Immunol Lett (2020) 217:91–115. doi: 10.1016/j.imlet.2019.11.007
10. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, et al. Directed Migration of Neural Stem Cells to Sites of Cns Injury by the Stromal Cell-Derived Factor 1alpha/Cxc Chemokine Receptor 4 Pathway. Proc Natl Acad Sci USA (2004) 101:18117–22. doi: 10.1073/pnas.0408258102
11. Kucia M, Dawn B, Hunt G, Guo Y, Wysoczynski M, Majka M, et al. Cells Expressing Early Cardiac Markers Reside in the Bone Marrow and Are Mobilized Into the Peripheral Blood After Myocardial Infarction. Circ Res (2004) 95:1191–9. doi: 10.1161/01.RES.0000150856.47324.5b
12. Tögel F, Isaac J, Hu Z, Weiss K, Westenfelder C. Renal SDF-1 Signals Mobilization and Homing of CXCR4-Positive Cells to the Kidney After Ischemic Injury. Kidney Int (2005) 67:1772–84. doi: 10.1111/j.1523-1755.2005.00275.x
13. Dalakas E, Newsome PN, Harrison DJ, Plevris JN. Hematopoietic Stem Cell Trafficking in Liver Injury. FASEB J Off Publ Fed Am Soc Exp Biol (2005) 19:1225–31. doi: 10.1096/fj.04-2604rev
14. Leung TH, Snyder ER, Liu Y, Wang J, Kim SK. A Cellular, Molecular, and Pharmacological Basis for Appendage Regeneration in Mice. Genes Dev (2015) 29:2097–107. doi: 10.1101/gad.267724.115
15. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al. Progenitor Cell Trafficking Is Regulated by Hypoxic Gradients Through Hif-1 Induction of Sdf-1. Nat Med (2004) 10:858–64. doi: 10.1038/nm1075
16. Moser B, Loetscher P. Lymphocyte Traffic Control by Chemokines. Nat Immunol (2001) 2:123–8. doi: 10.1038/84219
17. Uhl B, Vadlau Y, Zuchtriegel G, Nekolla K, Sharaf K, Gaertner F, et al. Aged Neutrophils Contribute to the First Line of Defense in the Acute Inflammatory Response. Blood (2016) 128:2327–37. doi: 10.1182/blood-2016-05-718999
18. Yamada M, Kubo H, Kobayashi S, Ishizawa K, He M, Suzuki T, et al. the Increase in Surface Cxcr4 Expression on Lung Extravascular Neutrophils and its Effects on Neutrophils During Endotoxin-Induced Lung Injury. Cell Mol Immunol (2011) 8:305–14. doi: 10.1038/cmi.2011.8
19. Liepelt A, Tacke F. Stromal Cell-Derived Factor-1 (SDF-1) as a Target in Liver Diseases. Am J Physiol Gastrointest Liver Physiol (2016) 311:G203–209. doi: 10.1152/ajpgi.00193.2016
20. Perkins GR, Marshall CJ, Collins MK. The Role of MAP Kinase Kinase in Interleukin-3 Stimulation of Proliferation. Blood (1996) 87:3669–75. doi: 10.1182/blood.V87.9.3669.bloodjournal8793669
21. Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 Pathway in Cancer. Clin Cancer Res Off J Am Assoc Cancer Res (2010) 16:2927–31. doi: 10.1158/1078-0432.Ccr-09-2329
22. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM. The Stromal Derived Factor-1/CXCL12-CXC Chemokine Receptor 4 Biological Axis in non-Small Cell Lung Cancer Metastases. Am J Respir Crit Care Med (2003) 167:1676–86. doi: 10.1164/rccm.200301-071OC
23. Jeong YM, Cheng XW, Lee S, Lee KH, Cho H, Kang JH, et al. Preconditioning With Far-Infrared Irradiation Enhances Proliferation, Cell Survival, and Migration of Rat Bone Marrow-Derived Stem Cells Via Cxcr4-Erk Pathways. Sci Rep (2017) 7:13718. doi: 10.1038/s41598-017-14219-w
24. Wei JN, Cai F, Wang F, Wu XT, Liu L, Hong X, et al. Transplantation of Cxcr4 Overexpressed Mesenchymal Stem Cells Augments Regeneration in Degenerated Intervertebral Discs. DNA Cell Biol (2016) 35:241–8. doi: 10.1089/dna.2015.3118
25. Ieranò C, Santagata S, Napolitano M, Guardia F, Grimaldi A, Antignani E, et al. Cxcr4 and Cxcr7 Transduce Through Mtor in Human Renal Cancer Cells. Cell Death Dis (2014) 5:e1310. doi: 10.1038/cddis.2014.269
26. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, et al. the Alpha-Chemokine, Stromal Cell-Derived Factor-1alpha, Binds to the Transmembrane G-Protein-Coupled Cxcr-4 Receptor and Activates Multiple Signal Transduction Pathways. J Biol Chem (1998) 273:23169–75. doi: 10.1074/jbc.273.36.23169
27. Wynn RF, Hart CA, Corradi-Perini C, O’Neill L, Evans CA, Wraith JE, et al. a Small Proportion of Mesenchymal Stem Cells Strongly Expresses Functionally Active Cxcr4 Receptor Capable of Promoting Migration to Bone Marrow. Blood (2004) 104:2643–5. doi: 10.1182/blood-2004-02-0526
28. Zhang D, Fan GC, Zhou X, Zhao T, Pasha Z, Xu M, et al. Over-Expression of Cxcr4 on Mesenchymal Stem Cells Augments Myoangiogenesis in the Infarcted Myocardium. J Mol Cell Cardiol (2008) 44:281–92. doi: 10.1016/j.yjmcc.2007.11.010
29. Lau TT, Wang DA. Stromal Cell-Derived Factor-1 (SDF-1): Homing Factor for Engineered Regenerative Medicine. Expert Opin Biol Ther (2011) 11:189–97. doi: 10.1517/14712598.2011.546338
30. Deveza L, Choi J, Lee J, Huang N, Cooke J, Yang F. Polymer-DNA Nanoparticle-Induced CXCR4 Overexpression Improves Stem Cell Engraftment and Tissue Regeneration in a Mouse Hindlimb Ischemia Model. Theranostics (2016) 6:1176–89. doi: 10.7150/thno.12866
31. Ding BS, Cao Z, Lis R, Nolan DJ, Guo P, Simons M, et al. Divergent Angiocrine Signals From Vascular Niche Balance Liver Regeneration and Fibrosis. Nature (2014) 505:97–102. doi: 10.1038/nature12681
32. Guo R, Chai L, Chen L, Chen W, Ge L, Li X, et al. Stromal Cell-Derived Factor 1 (Sdf-1) Accelerated Skin Wound Healing by Promoting the Migration and Proliferation of Epidermal Stem Cells. Vitro Cell Dev Biol Anim (2015) 51:578–85. doi: 10.1007/s11626-014-9862-y
33. Tirone M, Tran NL, Ceriotti C, Gorzanelli A, Canepari M, Bottinelli R, et al. High Mobility Group Box 1 Orchestrates Tissue Regeneration Via Cxcr4. J Exp Med (2018) 215:303–18. doi: 10.1084/jem.20160217
34. Shi W, Huang CJ, Xu XD, Jin GH, Huang RQ, Huang JF, et al. Transplantation of Rada16-Bdnf Peptide Scaffold With Human Umbilical Cord Mesenchymal Stem Cells Forced With Cxcr4 and Activated Astrocytes for Repair of Traumatic Brain Injury. Acta Biomater (2016) 45:247–61. doi: 10.1016/j.actbio.2016.09.001
35. Karin M, Clevers H. Reparative Inflammation Takes Charge of Tissue Regeneration. Nature (2016) 529:307–15. doi: 10.1038/nature17039
36. Nathan C. Neutrophils and Immunity: Challenges and Opportunities. Nat Rev Immunol (2006) 6:173–82. doi: 10.1038/nri1785
37. Mayadas TN, Cullere X, Lowell CA. The Multifaceted Functions of Neutrophils. Annu Rev Pathol (2014) 9:181–218. doi: 10.1146/annurev-pathol-020712-164023
38. Nauseef WM, Borregaard N. Neutrophils At Work. Nat Immunol (2014) 15:602–11. doi: 10.1038/ni.2921
39. Soehnlein O, Lindbom L. Phagocyte Partnership During the Onset and Resolution of Inflammation. Nat Rev Immunol (2010) 10:427–39. doi: 10.1038/nri2779
40. Martin C, Burdon PC, Bridger G, Gutierrez-Ramos JC, Williams TJ, Rankin SM. Chemokines Acting Via CXCR2 and CXCR4 Control the Release of Neutrophils From the Bone Marrow and Their Return Following Senescence. Immunity (2003) 19:583–93. doi: 10.1016/s1074-7613(03)00263-2
41. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. Cell Migration: Integrating Signals From Front to Back. Sci (New York NY) (2003) 302:1704–9. doi: 10.1126/science.1092053
42. Peng LH, Mao ZY, Qi XT, Chen X, Li N, Tabata Y, et al. Transplantation of Bone-Marrow-Derived Mesenchymal and Epidermal Stem Cells Contribute to Wound Healing With Different Regenerative Features. Cell Tissue Res (2013) 352:573–83. doi: 10.1007/s00441-013-1609-7
43. Forbes SJ, Rosenthal N. Preparing the Ground for Tissue Regeneration: From Mechanism to Therapy. Nat Med (2014) 20:857–69. doi: 10.1038/nm.3653
44. Takeo M, Lee W, Ito M. Wound Healing and Skin Regeneration. Cold Spring Harbor Perspect Med (2015) 5:a023267. doi: 10.1101/cshperspect.a023267
45. Liehn EA, Tuchscheerer N, Kanzler I, Drechsler M, Fraemohs L, Schuh A, et al. Double-Edged Role of the Cxcl12/Cxcr4 Axis in Experimental Myocardial Infarction. J Am Coll Cardiol (2011) 58:2415–23. doi: 10.1016/j.jacc.2011.08.033
46. Nishimura Y, Ii M, Qin G, Hamada H, Asai J, Takenaka H, et al. Cxcr4 Antagonist Amd3100 Accelerates Impaired Wound Healing in Diabetic Mice. J Invest Dermatol (2012) 132:711–20. doi: 10.1038/jid.2011.356
47. Lee Y, Gotoh A, Kwon HJ, You M, Kohli L, Mantel C, et al. Enhancement of Intracellular Signaling Associated With Hematopoietic Progenitor Cell Survival in Response to Sdf-1/Cxcl12 in Synergy With Other Cytokines. Blood (2002) 99:4307–17. doi: 10.1182/blood.v99.12.4307
48. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning Enhances Cell Survival and Differentiation of Stem Cells During Transplantation in Infarcted Myocardium. Cardiovasc Res (2008) 77:134–42. doi: 10.1093/cvr/cvm025
49. Liebmann C, Böhmer FD. Signal Transduction Pathways of G Protein-Coupled Receptors and Their Cross-Talk With Receptor Tyrosine Kinases: Lessons From Bradykinin Signaling. Curr Med Chem (2000) 7:911–43. doi: 10.2174/0929867003374589
50. Ngo HT, Leleu X, Lee J, Jia X, Melhem M, Runnels J, et al. Sdf-1/Cxcr4 and Vla-4 Interaction Regulates Homing in Waldenstrom Macroglobulinemia. Blood (2008) 112:150–8. doi: 10.1182/blood-2007-12-129395
51. Sanz-Rodríguez F, Hidalgo A, Teixidó J. Chemokine Stromal Cell-Derived Factor-1alpha Modulates VLA-4 Integrin-Mediated Multiple Myeloma Cell Adhesion to CS-1/Fibronectin and VCAM-1. Blood (2001) 97:346–51. doi: 10.1182/blood.v97.2.346
52. Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, Grabovsky V, et al. the Chemokine Sdf-1 Activates the Integrins Lfa-1, Vla-4, and Vla-5 on Immature Human Cd34(+) Cells: Role in Transendothelial/Stromal Migration and Engraftment of Nod/Scid Mice. Blood (2000) 95:3289–96. doi: 10.1182/blood.V95.11.3289.011k33_3289_3296
53. Engl T, Relja B, Marian D, Blumenberg C, Müller I, Beecken WD, et al. Cxcr4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion Through Alpha5 and Beta3 Integrins. Neoplasia (New York NY) (2006) 8:290–301. doi: 10.1593/neo.05694
54. Sun YX, Fang M, Wang J, Cooper CR, Pienta KJ, Taichman RS. Expression and Activation of Alpha V Beta 3 Integrins by SDF-1/CXC12 Increases the Aggressiveness of Prostate Cancer Cells. Prostate (2007) 67:61–73. doi: 10.1002/pros.20500
55. Shen W, Bendall LJ, Gottlieb DJ, Bradstock KF. The Chemokine Receptor CXCR4 Enhances Integrin-Mediated in Vitro Adhesion and Facilitates Engraftment of Leukemic Precursor-B Cells in the Bone Marrow. Exp Hematol (2001) 29:1439–47. doi: 10.1016/s0301-472x(01)00741-x
56. Zhu Y, Yang P, Wang Q, Hu J, Xue J, Li G, et al. the Effect of Cxcr4 Silencing on Epithelial-Mesenchymal Transition Related Genes in Glioma U87 Cells. Anat Rec (Hoboken NJ 2007) (2013) 296:1850–6. doi: 10.1002/ar.22821
57. Liles WC, Broxmeyer HE, Rodger E, Wood B, Hübel K, Cooper S, et al. Mobilization of Hematopoietic Progenitor Cells in Healthy Volunteers by Amd3100, a Cxcr4 Antagonist. Blood (2003) 102:2728–30. doi: 10.1182/blood-2003-02-0663
58. Parmo-Cabañas M, Bartolomé RA, Wright N, Hidalgo A, Drager AM, Teixidó J. Integrin Alpha4beta1 Involvement in Stromal Cell-Derived Factor-1alpha-Promoted Myeloma Cell Transendothelial Migration and Adhesion: Role of Camp and the Actin Cytoskeleton in Adhesion. Exp Cell Res (2004) 294:571–80. doi: 10.1016/j.yexcr.2003.12.003
59. Quesenberry PJ, Colvin G, Abedi M. Perspective: Fundamental and Clinical Concepts on Stem Cell Homing and Engraftment: A Journey to Niches and Beyond. Exp Hematol (2005) 33:9–19. doi: 10.1016/j.exphem.2004.10.012
60. Lutzny G, Kocher T, Schmidt-Supprian M, Rudelius M, Klein-Hitpass L, Finch AJ, et al. Protein Kinase C-β-Dependent Activation of Nf-κb in Stromal Cells is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells in Vivo. Cancer Cell (2013) 23:77–92. doi: 10.1016/j.ccr.2012.12.003
61. Legate KR, Montañez E, Kudlacek O, Fässler R. ILK, PINCH and Parvin: The Tipp of Integrin Signalling. Nat Rev Mol Cell Biol (2006) 7:20–31. doi: 10.1038/nrm1789
62. Desgrosellier JS, Cheresh DA. Integrins in Cancer: Biological Implications and Therapeutic Opportunities. Nat Rev Cancer (2010) 10:9–22. doi: 10.1038/nrc2748
63. Lauffenburger DA, Horwitz AF. Cell Migration: A Physically Integrated Molecular Process. Cell (1996) 84:359–69. doi: 10.1016/s0092-8674(00)81280-5
64. Beningo KA, Dembo M, Kaverina I, Small JV, Wang YL. Nascent Focal Adhesions are Responsible for the Generation of Strong Propulsive Forces in Migrating Fibroblasts. J Cell Biol (2001) 153:881–8. doi: 10.1083/jcb.153.4.881
65. Galbraith CG, Yamada KM, Sheetz MP. The Relationship Between Force and Focal Complex Development. J Cell Biol (2002) 159:695–705. doi: 10.1083/jcb.200204153
66. Sánchez-Madrid F, del Pozo MA. Leukocyte Polarization in Cell Migration and Immune Interactions. EMBO J (1999) 18:501–11. doi: 10.1093/emboj/18.3.501
67. Butcher EC, Picker LJ. Lymphocyte Homing and Homeostasis. Sci (New York NY) (1996) 272:60–6. doi: 10.1126/science.272.5258.60
68. Wang JF, Park IW, Groopman JE. Stromal Cell-Derived Factor-1alpha Stimulates Tyrosine Phosphorylation of Multiple Focal Adhesion Proteins and Induces Migration of Hematopoietic Progenitor Cells: Roles of Phosphoinositide-3 Kinase and Protein Kinase C. Blood (2000) 95:2505–13. doi: 10.1182/blood.V95.8.2505.008k24_2505_2513
69. Zhang XF, Wang JF, Matczak E, Proper JA, Groopman JE. Janus Kinase 2 is Involved in Stromal Cell-Derived Factor-1alpha-Induced Tyrosine Phosphorylation of Focal Adhesion Proteins and Migration of Hematopoietic Progenitor Cells. Blood (2001) 97:3342–8. doi: 10.1182/blood.v97.11.3342
70. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, et al. Extracellular Matrix Proteins Protect Small Cell Lung Cancer Cells Against Apoptosis: A Mechanism for Small Cell Lung Cancer Growth and Drug Resistance in Vivo. Nat Med (1999) 5:662–8. doi: 10.1038/9511
71. Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, et al. Cxcl12 / Cxcr4 / Cxcr7 Chemokine Axis and Cancer Progression. Cancer Metastasis Rev (2010) 29:709–22. doi: 10.1007/s10555-010-9256-x
72. Daniel SK, Seo YD, Pillarisetty VG. The CXCL12-CXCR4/CXCR7 Axis as a Mechanism of Immune Resistance in Gastrointestinal Malignancies. Semin Cancer Biol (2020) 65:176–88. doi: 10.1016/j.semcancer.2019.12.007
73. Takesono A, Horai R, Mandai M, Dombroski D, Schwartzberg PL. Requirement for Tec Kinases in Chemokine-Induced Migration and Activation of Cdc42 and Rac. Curr Biol CB (2004) 14:917–22. doi: 10.1016/j.cub.2004.04.011
74. Fischer AM, Mercer JC, Iyer A, Ragin MJ, August A. Regulation of CXC Chemokine Receptor 4-Mediated Migration by the Tec Family Tyrosine Kinase ITK. J Biol Chem (2004) 279:29816–20. doi: 10.1074/jbc.M312848200
75. Ottoson NC, Pribila JT, Chan AS, Shimizu Y. Cutting Edge: T Cell Migration Regulated by CXCR4 Chemokine Receptor Signaling to ZAP-70 Tyrosine Kinase. J Immunol (Baltimore Md 1950) (2001) 167:1857–61. doi: 10.4049/jimmunol.167.4.1857
76. Wang K, Zhao X, Kuang C, Qian D, Wang H, Jiang H, et al. Overexpression of Sdf-1α Enhanced Migration and Engraftment of Cardiac Stem Cells and Reduced Infarcted Size Via Cxcr4/Pi3k Pathway. PloS One (2012) 7:e43922. doi: 10.1371/journal.pone.0043922
77. Ko IK, Lee SJ, Atala A, Yoo JJ. In Situ Tissue Regeneration Through Host Stem Cell Recruitment. Exp Mol Med (2013) 45:e57. doi: 10.1038/emm.2013.118
78. Leeper NJ, Hunter AL, Cooke JP. Stem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells. Circulation (2010) 122:517–26. doi: 10.1161/circulationaha.109.881441
79. Rennert RC, Sorkin M, Garg RK, Gurtner GC. Stem Cell Recruitment After Injury: Lessons for Regenerative Medicine. Regen Med (2012) 7:833–50. doi: 10.2217/rme.12.82
80. Hocking AM. The Role of Chemokines in Mesenchymal Stem Cell Homing to Wounds. Adv Wound Care (2015) 4:623–30. doi: 10.1089/wound.2014.0579
81. Fadini GP, Ferraro F, Quaini F, Asahara T, Madeddu P. Concise Review: Diabetes, the Bone Marrow Niche, and Impaired Vascular Regeneration. Stem Cells Trans Med (2014) 3:949–57. doi: 10.5966/sctm.2014-0052
82. Penn MS. Importance of the SDF-1:CXCR4 Axis in Myocardial Repair. Circ Res (2009) 104:1133–5. doi: 10.1161/circresaha.109.198929
83. Tapia JA, Camello C, Jensen RT, García LJ. EGF Stimulates Tyrosine Phosphorylation of Focal Adhesion Kinase (P125fak) and Paxillin in Rat Pancreatic Acini by a Phospholipase C-Independent Process That Depends on Phosphatidylinositol 3-Kinase, the Small GTP-Binding Protein, P21rho, and the Integrity of the Actin Cytoskeleton. Biochim Biophys Acta (1999) 1448:486–99. doi: 10.1016/s0167-4889(98)00157-8
84. Ward SG. T Lymphocytes on the Move: Chemokines, PI 3-Kinase and Beyond. Trends Immunol (2006) 27:80–7. doi: 10.1016/j.it.2005.12.004
85. Merlot S, Firtel RA. Leading the Way: Directional Sensing Through Phosphatidylinositol 3-Kinase and Other Signaling Pathways. J Cell Sci (2003) 116:3471–8. doi: 10.1242/jcs.00703
86. Tan SL, Parker PJ. Emerging and Diverse Roles of Protein Kinase C in Immune Cell Signalling. Biochem J (2003) 376:545–52. doi: 10.1042/bj20031406
87. Ward SG, Bacon K, Westwick J. Chemokines and T Lymphocytes: More Than an Attraction. Immunity (1998) 9:1–11. doi: 10.1016/s1074-7613(00)80583-x
88. Trautmann F, Cojoc M, Kurth I, Melin N, Bouchez LC, Dubrovska A, et al. Cxcr4 as Biomarker for Radioresistant Cancer Stem Cells. Int J Radiat Biol (2014) 90:687–99. doi: 10.3109/09553002.2014.906766
89. Fontanella R, Pelagalli A, Nardelli A, D’Alterio C, Ieranò C, Cerchia L, et al. a Novel Antagonist of Cxcr4 Prevents Bone Marrow-Derived Mesenchymal Stem Cell-Mediated Osteosarcoma and Hepatocellular Carcinoma Cell Migration and Invasion. Cancer Lett (2016) 370:100–7. doi: 10.1016/j.canlet.2015.10.018
90. Kim SY, Nair MG. Macrophages in Wound Healing: Activation and Plasticity. Immunol Cell Biol (2019) 97:258–67. doi: 10.1111/imcb.12236
91. Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, et al. Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice. PloS One (2010) 5:e9539. doi: 10.1371/journal.pone.0009539
92. Jiang C, Ma S, Hu R, Wang X, Li M, Tian F, et al. Effect of Cxcr4 on Apoptosis in Osteosarcoma Cells Via the Pi3k/Akt/Nf-κβ Signaling Pathway. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol (2018) 46:2250–60. doi: 10.1159/000489593
93. Datta SR, Brunet A, Greenberg ME. Cellular Survival: A Play in Three Akts. Genes Dev (1999) 13:2905–27. doi: 10.1101/gad.13.22.2905
94. Yi J, Gao ZF. Microrna-9-5p Promotes Angiogenesis But Inhibits Apoptosis and Inflammation of High Glucose-Induced Injury in Human Umbilical Vascular Endothelial Cells by Targeting CXCR4. Int J Biol Macromol (2019) 130:1–9. doi: 10.1016/j.ijbiomac.2019.02.003
95. Abraham M, Klein S, Bulvik B, Wald H, Weiss ID, Olam D, et al. the Cxcr4 Inhibitor Bl-8040 Induces the Apoptosis of Aml Blasts by Downregulating Erk, Bcl-2, Mcl-1 and Cyclin-D1 Via Altered Mir-15a/16-1 Expression. Leukemia (2017) 31:2336–46. doi: 10.1038/leu.2017.82
96. Wang W, Zhang Y, Liu W, Xiao H, Zhang Q, Wang J, et al. Lmp1-Mir-146a-Cxcr4 Axis Regulates Cell Proliferation, Apoptosis and Metastasis. Virus Res (2019) 270:197654. doi: 10.1016/j.virusres.2019.197654
Keywords: CXCR4, wound healing, inflammation, proliferation, adhesion, chemotaxis, apoptosis
Citation: Chen H, Li G, Liu Y, Ji S, Li Y, Xiang J, Zhou L, Gao H, Zhang W, Sun X, Fu X and Li B (2021) Pleiotropic Roles of CXCR4 in Wound Repair and Regeneration. Front. Immunol. 12:668758. doi: 10.3389/fimmu.2021.668758
Received: 17 February 2021; Accepted: 26 April 2021;
Published: 28 May 2021.
Edited by:
Meijing Wang, Indiana University Bloomington, United StatesReviewed by:
Kanhaiya Singh, Purdue University Indianapolis, United StatesJia Yao, Emory University, United States
Copyright © 2021 Chen, Li, Liu, Ji, Li, Xiang, Zhou, Gao, Zhang, Sun, Fu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiaoyan Sun, yanzisun1979@sina.com; Xiaobing Fu, fuxiaobing@vip.sina.com; Binghui Li, libinghui2006@sina.com; email@uni.edu
†These authors have contributed equally to this work